Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir Pharmacology in HIV-1 Reservoirs
NCT02924389Phase 4Terminated
- Sponsor
- Emory University
- Start
- Sep 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dolutegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Emory University. Started Sep 2016; status: terminated.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02924389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924389.